ArticleFrontiers in neurology2026

Efficacy and safety of low-dose rituximab in MuSK antibody-positive myasthenia gravis: a single-center retrospective study.

Li Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.